Skip to main content
Leading small business innovation and commercialization in the fight against cancer
Watch NIH at BIO 2014



What are SBIR & STTR?

The National Cancer Institute is committed to dramatically lessening the impact of cancer.

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs are NCI’s engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer.

The SBIR & STTR Programs are one of the largest sources of early-stage technology financing in the United States. We welcome entrepreneurs and small business leaders to this website to explore grant and contract funding opportunities and a new spirit of collaboration with the NCI.

[Learn More]

Michael Weingarten, Director of the NCI SBIR & STTR Programs discusses how the program began and why it is so important to improving cancer treatments and care for patients.



Stay Connected

Sign up to receive updates and news about the NCI SBIR & STTR Programs and upcoming funding opportunities.

Sign Up or Change your Subscription

Follow us on Twitter

Connect with us on LinkedIn



Share Your Company's Success Story

The NCI SBIR Development Center is interested in learning more about how SBIR & STTR funding is helping your company to achieve its cancer research goals and business objectives. Please click here to fill out a 'Share Your Story' form, and let us know about any developments with your NCI SBIR- or STTR-funded projects. Learn more about how other successful NCI SBIR & STTR companies are using their funding awards to advance cancer research.



Tips for Applying: Granting You Success

Learn about Funding & Resources Available from the NCI SBIR & STTR Programs


Nature Biotechnology Publishes Article on the SBIR & STTR Programs

In an article published in Nature Biotechnology, SBIR & STTR Development Center staff discuss the application process and provide tips for applying for funding through the SBIR & STTR Programs.

Latest Announcements

You are invited to the NCI SBIR Investor Forum, November 13, 2014, Santa Clara, CA.

2014 NCI SBIR Investor Forum

Join the NCI SBIR Investor Forum on November 13, 2014 for a day of networking and presentations from the top SBIR-funded companies with innovative cancer-related technologies on the brink of commercialization.




New Contract Funding Available

The NCI SBIR Program announced 7 new contract funding opportunities.
Learn more about the new contract topics
Receipt Date: November 5, 2014
View the slides from the webinar on 9/18.




I-Corps at NIH

Download slides from a webinar about the I-Corps™ at NIH pilot program, which seeks to accelerate development and commercialization of new SBIR/STTR-funded products and services.





AdvaMed 2014 has selected 12 NIH-funded companies as Emerging Growth Company scholars to attend and present at the medtech conference this October.





Understanding the SBIR/STTR Resubmission Policy

Learn how the new NIH Resubmission Policy affects SBIR and STTR applications. Effective April 17, 2014




2014 SBIR & STTR Omnibus Solicitation:

2014 Receipt date: December 5




2014 SBIR Direct to Phase II Solicitation:

2014 Receipt date: December 5